Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
NCT00036179 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2018-01-10
Summary
The purpose of the study is to evaluate the safety and efficacy of FK463 in the treatment of patients with confirmed candidemia or invasive candidiasis.
Conditions
- Candidiasis
Interventions
- DRUG
-
FK463
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-02-27
- Primary Completion
- 2002-01-27
- Completion
- 2002-01-27
Countries
- Austria
- France
- Germany
- Italy
- Poland
- Spain
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis
NCT01176058 ·Status: TERMINATED ·Phase: PHASE3
-
The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.
NCT00037219 ·Status: COMPLETED ·Phase: PHASE2
-
Anidulafungin Versus Fluconazole in the Treatment of Candidemia
NCT00058682 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
NCT00304772 ·Status: WITHDRAWN ·Phase: PHASE4
-
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia
NCT00001790 ·Status: COMPLETED ·Phase: PHASE1
-
Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia
NCT00106288 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU
NCT00048750 ·Status: TERMINATED ·Phase: PHASE3
-
The Study Of Fluconazole For Vulvovaginal Candidiasis
NCT01806623 ·Status: COMPLETED ·Phase: PHASE3
-
Anidulafungin In Treatment Of Candidemia In Asian Subjects
NCT00537329 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)
NCT00041704 ·Status: COMPLETED ·Phase: PHASE2
-
Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study
NCT00689338 ·Status: COMPLETED ·Phase: PHASE3
-
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
NCT00083343 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
NCT05178862 ·Status: TERMINATED ·Phase: PHASE3
-
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002304 ·Status: COMPLETED ·Phase: NA
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole
NCT00005920 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002339 ·Status: COMPLETED ·Phase: PHASE3
-
PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)
NCT00034671 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects
NCT01122368 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
NCT00000744 ·Status: COMPLETED ·Phase: NA
-
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
NCT00002399 ·Status: COMPLETED ·Phase: PHASE2
-
Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections
NCT00721487 ·Status: COMPLETED
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
NCT02734862 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
NCT00002132 ·Status: COMPLETED ·Phase: NA